The
end of the annus horribilis is at hand, and despite the hard winter ahead for
the northern hemisphere, there is a sense of optimism for the new year.
The first generation of vaccines for the coronavirus appears promising. The US
has elected as president a person who is within the internationalist
tradition. The UK's standstill agreement with the EU will still expire at
the end of the year, but many are still hopeful a last-minute deal can still be
struck. China has entered into the large regional free-trade agreement and
allowed the yuan to appreciate by considerably more than even yuan bulls like
us imagined. The yuan's year-to-date gain of 6% rival the Bulgarian lev
as the top performer among emerging market currencies through November.
It will the yuan's first annual increase since 2017 when it appreciated by a
little more than 7%.
The prospect that the Covid-19 can be brought under control
spurred a shift in portfolio allocation. On the one hand, market breadth
increased, and on the other, value overperformed growth. The Russell 2000
in the US rose over 17% last month, easily besting the NASDAQ and S&P
500. Among the major equity markets, Japan is seen as a "value
play" as price-to-book multiples are around a third of what they are in
the US. Foreign investors have returned to being net buyers here in Q4
(~$16 bln) after having sold around $83 bln of Japanese shares in the first
nine months of the year.
The backing up of bond yields that one would expect in the
reflation trade has arguable been kept in check by expectations that both the
Federal Reserve and European Central Bank will do more to support the bond
market at policy meetings in December. The ECB has all but promised to
expand and extend its Pandemic Emergency Purchases Program by several hundred
billion euros (400-600 bln) and offer new attractive loans at an interest rate
of minus 100 bp provided certain lending targets are reached. The Federal
Reserve is expected to shift its purchases toward the longer end of the
curve. There is some speculation that the Fed may increase the amount of
Treasuries it is buying (currently $80 bln of Treasuries and $40 bln
Agency mortgage-backed securities a month). Given some official comments, there
may not be a majority that favors an increase now.
The prospects of a vaccine that could allow a return to a
new normal is seen as negative for the dollar. Those currencies that tend
to do well in periods of robust growth, the Antipodeans and Scandis shined in
November. The JP Morgan Emerging Markets Currency Index snapped a
three-month decline with more than a 1% increase. Rising commodity
prices, driven in part by strong Asian demand (especially China), were particularly
helpful for Latam currencies. The Colombian peso and Brazilian real were the
best performers, up 7.5% and 7.2%, respectively. Turkey's apparent adoption of
orthodox monetary policy triggered a short squeeze that lifted around 12% in
the first few weeks before the gains were halved in the second half of the
month. Still, its 6.7% gain in November was only the second monthly rise
since the end of Q3 19.
Our longer-term view that the dollar's third significant
rally since the end of Bretton Woods is over remains intact, and we expect the
greenback to decline in 2021 as we expected in 2020. However, more
immediately, the US economy's resilience leaves the dollar with scope to firm
into the end of the year after its broad decline in November. Still, it
is likely to remain rangebound against most of the major currencies as it has
since early Q3.
The dollar fell for a sixth consecutive month against the
Chinese yuan. Since the yuan is closely managed, its appreciation to new
two-year highs is likely because Beijing is accepting it. Officials have taken
advantage of its appreciation to ease capital outflow rules, and reduce reserve
requirements for foreign exchange forward, and made the setting of the daily
reference rate more transparent and predictable.
The large surplus shows the yuan is competitive for trade
purposes. Yet, China's integration into the world's capital markets, what
we have dubbed the internationalization of the yuan 2.0, requires a stronger
yuan, but really one that reflects the reasonable expectations of the managers
of the world's savings. China's high-interest rates (3.2%+ on the 10-year
bond), perhaps the only G20 economy to expand this year, and the large current
account surplus would be associated with an appreciating currency. If it
does not materialize, Chinese officials seem to recognize, it would deter
global asset managers. Nevertheless, the consolidation and partial trimming of
the dollar's November losses suggests some modest gains against the yuan as
well ahead of year-end.
Dollar: The macro forces that drive the $6.6
trillion a day foreign exchange market are larger than who occupies the White
House. The twin deficits offer a framework to understand the dollar's downside pressure when growth and rate differentials are less supportive.
However, more immediately, the US economy will likely prove more resilient than
Europe and Japan. Its social restrictions were introduced later and have
generally been milder. This could underpin it into the end of the year.
Yet, without at least renewing various income support programs and the
foreclosure and eviction prohibitions, a fiscal cliff could weaken the US
economy in Q1 21, just as the eurozone and Japan rebound. The Federal
Reserve's last meeting of the year concludes on December 16. It is widely
expected to shift its purchases to favor longer-term bonds. Some economists warn it could increase the amount of its bond purchases, though
we are less sanguine. The failure to extend several of the Fed's
emergency facilities into next year may say more about the US political climate
than about the central bank's preparedness for another crisis.
Euro: There is little doubt of what the
ECB will do when it meets on December 10. It will expand its emergency
bond-buying program and extend it through the end of 2021. ECB President
Lagarde will likely indicate that the central bank is prepared to do more if
necessary. With new social restrictions in place, some of which are
likely to extend into December, large parts of the European economy will
contract in Q4. The failure of negotiators to reach a new trade accord with the
UK could see the euro appreciate against sterling and possibly spill over
against the dollar. The euro remains in a $1.16-$1.20 trading range as it
has since late July, and while we expect the breakout to be on the topside, it
may have to wait until next year for a sustained move. That said, a
convincing move above $1.20 gives scope for another two-cent
advance.
(end of November indicative prices,
previous in parentheses)
Spot: $1.1925 ($1.1645)
Median Bloomberg One-month Forecast
$1.1850 ($1.1725)
One-month forward $1.1940 ($1.1655) One-month
implied vol 6.2% (7.9%)
Yen: The dollar successfully tested support around
JPY104 in July, September, and October before finally the bears succeeded and
took it to about JPY103.20 in early November. Two factors helped the greenback
recover and snap the yen's appeal: the end of political uncertainty in the US
and the enhanced prospects for vaccines to protect from the coronavirus.
The historic rally in equities also dimmed the attractiveness of the safe-haven
characteristics of the yen. Even if the lower end of the dollar's range
expanded, the upper end has not. The JPY106.00 area still ought to cap
dollar bounces. The Japanese government is putting together a third
supplemental budget, but only about half is seen as new funds. The Bank of
Japan meets on December 18 and is not expected to change policy, even though the
2019 sales tax increase has dropped out of the year-over-year comparisons
showing deflationary pressures have not been fully arrested.
Spot: JPY104.30 (JPY104.65)
Median Bloomberg One-month Forecast
JPY104.00 (JPY104.85)
One-month forward JPY104.25 (JPY105.00) One-month
implied vol 5.8% (8.0%)
Sterling: The process that was started three and a
half years ago by a closely decided referendum, which was to be non-binding,
the UK will, in fact, leave the year-long standstill agreement with the EU at the
end of December. The key issue that remains at this late date is whether a new
trade agreement will be struck. Indeed, the year-end deadline seems to be
the only deadline that is sacrosanct. Many continue to expect a
last-minute deal suggesting the market reaction could be more dramatic if
officials fail. The EU accounts for nearly half of the UK's trade, but the UK
accounts for around 15-18% of the EU's trade. The Bank of England increased its
bond-buying program by GBP150 bln in November and is unlikely to take fresh
steps at the December 17 meeting. With prospects of a vaccine and some
official comments, the market has unwound expectations that the BOE would adopt
negative rates next year.
Spot: $1.3325 ($1.2950)
Median Bloomberg One-month Forecast
$1.3110 ($1.2975)
One-month forward $1.3330 ($1.2950) One-month implied
vol 9.8% (11.3%)
Canadian Dollar: The Canadian dollar's 2.5% gain last month
leaves it flat on the year. Only the Norwegian krone has done worse. (~-0.20%) among the majors. The strong risk appetites seen in the booming
equities are often associated with an appreciating Canadian dollar. The
Toronto Stock Exchange's 10.6% advance last month turned the index positive for
the year (~0.8%) and was the largest monthly since April. Oil prices and commodity
prices, in general, have risen, and this is also often supportive of the
Canadian dollar. The new spending measures announced at the end of
November will lift the projected deficit to C$381 bln in the fiscal year ending
March 31, more than 10% larger than projected in July. The deficit is
projected to fall to C$121 bln in the next fiscal year, without including the
additional but unspecified stimulus of C$70-C$100 bln cumulative over the next
three years, which is proportional to the size of the output gap the central
bank expects. Nevertheless, Trudeau's minority government is looking
increasingly vulnerable, and a snap election early next year has become more
likely.
Spot: CAD1.3000 (CAD 1.3320)
Median Bloomberg One-month Forecast
CAD1.3195 (CAD1.3285)
One-month forward CAD1.3005 (CAD1.3300) One-month
implied vol 6.5% (8.3%)
Australian Dollar: After setting the high for the year in
early September a little above $0.7400, the Australian dollar trended lower
through the start of November when it briefly slipped below $0.7000. The
optimism over the vaccine, the October jobs surge, other data showing the
recovery remains intact, and the broad US dollar weakness helped lift the
Australian dollar back to $0.7400 by the end of November. A move above
there would immediately target the $0.7500-$0.7550 area. Relations
with China, which absorbs around a third of Australia's exports, remain
strained, even though both are members of the new Regional Comprehensive
Economic Partnership, the largest free trade agreement in the world.
Since Australia's strategic and defense interests anchor it in the US-sphere,
the relationship may be difficult to improve, but Beijing could offer a
rapprochement as a modest gesture of good faith to the incoming US
administration.
Spot: $0.7345 ($0.7030)
Median Bloomberg One-Month Forecast
$0.7205 ($0.7115)
One-month forward $0.7340 ($0.7045)
One-month implied vol 9.3% (12.0%)
Mexican Peso: Driven by relatively high-interest rates,
large external surplus, a robust risk-appetite, and a rise in emerging market
currencies more broadly, the Mexican peso appreciated by about 5% in November,
nearly cutting the year's decline in half. JP Morgan's Emerging Market Currency
Index rose by almost 3.7% in November, stopping a three-month slide with its
biggest monthly advance in four years. With headline inflation above the upper
end of Banxico's 2-4% range, it stood pat in November. Inflation dipped in the
first half of November, apparently driven by early year-end sales. Still,
most economists expect the central bank to leave its cash target at 4.25% when
it meets on December 17. A surprise cut would likely weigh on the peso, but its
short-term rates will remain a powerful draw and may limit the peso's
downside.
Spot: MXN20.18 (MXN21.18)
Median Bloomberg One-Month Forecast
MXN20.21 (MXN21.60)
One-month forward MXN20.25 (MXN21.25) One-month
implied vol 13.4% (20.5%)
Chinese Yuan: The yuan strengthened to new
two-and-a-half years highs against the US dollar in November. After
appreciating in the first three weeks of last month, it entered a consolidative
phase toward the end of November. It culminated a six-month appreciating
trend, matching the longest run since 2011. The lower end of the dollar's new
range is around CNY6.54, and the upper end may extend toward CNY6.65. The
blocking of the Ant (Alibaba's financial arm) IPO, the rash of failures of
state-owned-enterprises, and the threat of more sanctions and bans by
Trump before he leaves office may be tempering foreign portfolio demand. US President-elect Biden's early nominations do not suggest that US efforts to
resist Beijing's efforts to dominate the South China Sea or its unfair gaming
of international trade norms will slacken even if the tactics change.
Spot: CNY6.5790 (CNY6.6915)
Median Bloomberg One-month Forecast
CNY6.6960 (CNY6.7210)
One-month forward CNY6.6025 (CNY6.7150) One-month
implied vol 5.2% (6.6%)